Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection

The 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) is < 8%. The best therapeutic option for PDAC is tumor resection. However, most patients experience recurrence within 2 years after surgery[1][1]. Postoperative monitoring includes CT imaging and determining CA19-9